Company reports all-time-high monthly cartridge sales for July with 60% year-on-year growthNEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its highest-ever monthly cartridge sales for July 2025, with a record 519 boxes shipped, representing over 12,500 cartridges and a 60% increase year-on-year. Cartridges, a higher-margin consumable ...

Company advanced efforts to secure U.S. FDA 510(k) clearance to advance on path towards planned U.S. market expansion beyond Forensic Use Only settings Fourth quarter sequential and year-on-year revenue growth of 16%, supported by increased demand for drug testing cartridges NEW YORK, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its financi ...

Company Overview - Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company focused on delivering intelligent, rapid, non-invasive testing solutions [3] - The company aims to revolutionize portable testing through its Intelligent Fingerprinting Drug Screening System, which analyzes fingerprint sweat [3] - The system is designed to be hygienic and cost-effective, screening for recent drug use including opiates, cocaine, methamphetamine, and cannabis [3] Technology and Applications - The Intelligent Fingerprinting Drug Screening System allows for sample collection in seconds and provides results in under ten minutes [3] - This technology is particularly valuable for employers in safety-critical industries, enhancing workplace safety [3] - Current customer segments outside the US include construction, manufacturing, engineering, transport and logistics, mining, drug treatment organizations, and coroners [3] Upcoming Events - The management team will participate in the Sidoti Micro-Cap Virtual Conference on August 20-21, 2025 [1] - A presentation is scheduled for August 21, 2025, at 9:15 a.m. Eastern Time [2] - Interested parties can register for the conference through a provided link and schedule one-on-one meetings with the management team [2]

Proceeds to Fund Completion of the Company’s 510k Filing with the U.S. FDA for its Fingerprint Drug Screening SystemNEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced an agreement between the Company and several current warrant holders to exercise (or prepay the exercise price) certain existing warrants to purchase up to 2,023,228 share ...

Data confirms Company's ability to detect trace sweat volumes at ultra-micro level System demonstrates resilience across diverse conditions NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful collection of new data that further reinforces the security and performance of its Intelligent Fingerprinting Drug Screening System, ...

Core Insights - Intelligent Bio Solutions Inc. has introduced the SmarTest® Patch, a non-invasive drug testing solution that detects substances through sweat over a 7 to 10-day period [1][2] - The SmarTest Patch complements the existing Intelligent Fingerprinting Drug Testing Solution, enhancing the company's product portfolio in non-invasive testing technologies [1][2] Product Features - The SmarTest Patch is discreet, water-resistant, and tamper-evident, designed to continuously collect sweat for drug detection [2] - It can detect a wide range of substances, including cocaine, opiates, methamphetamines, marijuana, and fentanyl [2] - The differing detection windows of the SmarTest Patch and the Intelligent Fingerprinting Drug Screening System allow the company to meet varied customer requirements [2][3] Market Opportunities - The introduction of the SmarTest Patch opens new opportunities in markets requiring longer detection windows, particularly in justice and rehabilitation settings [3] - The product enhances the company's commercial edge by providing customers with more adaptable tools for both short and long-term detection needs [3] Company Background - Intelligent Bio Solutions Inc. focuses on delivering rapid, non-invasive testing solutions and aims to revolutionize portable testing through fingerprint sweat analysis [5] - The company targets various customer segments outside the U.S., including construction, manufacturing, transport, and drug treatment organizations [5] Partner Information - SMARTOX, the developer of the SmarTest Patch, is a U.S.-based provider of drug and alcohol testing products and services, committed to advanced technology and exceptional results [4] - SMARTOX is actively expanding its presence in forensic testing markets through investments and pilot programs [4]

Core Insights - Intelligent Bio Solutions Inc. (INBS) is set to present its Pharmacokinetic (PK) study data at the ADLM 2025 Clinical Lab Expo, showcasing the effectiveness of its Intelligent Fingerprinting Drug Screening System for non-invasive drug testing [2][4]. Group 1: Study Findings - The PK study demonstrated that fingerprint sweat can accurately reflect the rate and extent of codeine found in blood and saliva, indicating its reliability for drug detection [3]. - Statistical comparisons at a 95% confidence level confirmed that fingerprint sweat serves as a dependable sample matrix for drug screening [3]. Group 2: Event Participation - Daniel Brown, Head of Clinical Affairs at INBS, will represent the company at the ADLM event, engaging with attendees and presenting the study's methodology and findings [4]. - ADLM 2025 is a significant global exposition for laboratory medicine, featuring over 300 expert speakers and more than 250 educational sessions [5]. Group 3: Company Overview - INBS's Drug Screening System is designed for accurate and efficient testing across various sectors, including construction, transportation, and manufacturing, with over 450 accounts in 24 countries [7]. - The Intelligent Fingerprinting Drug Screening System aims to revolutionize portable testing through rapid sample collection and results, making it a valuable tool for safety-critical industries [8].

Core Insights - Intelligent Bio Solutions Inc. (INBS) is advancing drug screening technology through its partnership with Spjotgard, enhancing the adoption of its Intelligent Fingerprinting Drug Screening System in Scandinavia [1][6] - Spjotgard, established in 2021, has positioned INBS' technology as a leading solution in response to the demand for modern drug testing methods [2][7] - The fingerprint drug testing system is gaining traction due to its non-invasive nature, quick results, and suitability for various sectors including logistics, construction, and education [3][5][10] Company Overview - Intelligent Bio Solutions Inc. specializes in non-invasive drug testing solutions, with a focus on fingerprint sweat analysis for rapid results [10] - The company has over 450 accounts across 24 countries, indicating a strong market presence and ongoing evolution in drug screening technology [6] - INBS' Drug Screening System is designed to be hygienic and cost-effective, screening for commonly used drugs in workplace settings [10] Market Dynamics - There is a growing interest in fingerprint-based testing in Scandinavia, driven by the need for more hygienic and less invasive drug testing alternatives [3][5] - Spjotgard is expanding its market presence through collaborations with drug-detection service providers and is actively targeting Norway for future growth [4][5] - The Scandinavian region, particularly Sweden, is recognized for its progressive drug testing policies, setting a standard for neighboring countries [5]

Core Insights - Intelligent Bio Solutions Inc. (INBS) has partnered with Managed Waste Service (MWS) to implement its Intelligent Fingerprinting Drug Screening System across MWS's operations in New South Wales, Australia [1][2] - This marks MWS's first initiative for in-house drug testing at over 20 sites, allowing for pre-employment, random, and for-cause testing on-site [2][3] - The Intelligent Fingerprinting Drug Screening System provides results in under ten minutes through fingerprint sweat analysis, enhancing safety and compliance in the workplace [3][4] Company Overview - Intelligent Bio Solutions Inc. specializes in rapid, non-invasive testing solutions, with a focus on drug screening through fingerprint analysis [1][6] - The company aims to revolutionize portable testing, offering a hygienic and cost-effective method to screen for drugs commonly found in the workplace [6] - INBS's technology is currently utilized by over 450 organizations across 24 countries, indicating a growing acceptance of sweat-based drug testing in various sectors [4][6] Industry Context - The implementation of INBS's drug screening system reflects a trend in safety-critical industries seeking innovative and scalable solutions for managing safety and risk [4] - The partnership with MWS highlights the increasing recognition of fingerprint drug testing as an effective and dignified option for workplace safety [4] - MWS is committed to landfill reduction and advancing a circular economy, providing waste management solutions that align with sustainability goals [5]

Core Insights - Intelligent Bio Solutions Inc. (INBS) is expanding its presence in the U.S. Forensic Use Only Market through a partnership with SMARTOX, having deployed over 50 Intelligent Fingerprinting Drug Screening Readers and conducted over 7,000 screening tests, including more than 1,500 in 2024 [1][2][3] Company Overview - INBS specializes in intelligent, rapid, non-invasive testing solutions, particularly in drug screening technology that reduces reliance on invasive methods [2][7] - SMARTOX, founded in 2012, provides drug and alcohol testing products and services across various sectors, including healthcare and criminal justice, and is committed to innovation and customer service [6] Market Demand and Technology - There is an accelerated demand for non-invasive, rapid testing in forensic settings, with INBS's technology credited for improving efficiency and user dignity while simplifying operations [2][5] - The Intelligent Fingerprinting Drug Screening System allows for hygienic, non-invasive drug screening in under ten minutes using fingerprint sweat, which is beneficial for safety-critical industries [4][7] Regulatory Efforts - INBS is actively pursuing FDA clearance for its opiate test system for codeine, aiming for broader market expansion in 2025, including workplace drug testing [3][4]